Guided Therapeutics (GTHP) Receivables - Other (2011 - 2022)

Guided Therapeutics (GTHP) posted Receivables - Other of $82984.0 for Q4 2022, up 92.73% sequentially from $43057.0 in Q3 2022.

Guided Therapeutics (GTHP) Receivables - Other (2011 - 2022) Analysis & Trends

Guided Therapeutics has reported Receivables - Other for 6 years, with the latest figure at $82984.0 in Q4 2022.

Quarterly Receivables - Other changed N/A year-over-year to $82984.0 in Q4 2022, while the trailing twelve-month figure through Dec 2022 was $82984.0 (changed N/A YoY) and the FY2022 annual result came in at $82984.0, changed N/A from the prior year.
Receivables - Other grew to $82984.0 in Q4 2022 per GTHP's latest filing, from $43057.0 in the prior quarter.
Over five years, Receivables - Other peaked at $350.0 million in Q2 2021 and troughed at $24785.0 in Q2 2022.
A 5-year average of $39.5 million and a median of $130000.0 in 2022 frame the typical range for Receivables - Other.
The sharpest annual moves came in 2021 and 2022: Receivables - Other jumped 3280.0% in 2021, then sank 99.99% in 2022.
Over 5 years, Receivables - Other stood at $661000.0 in 2018, then slipped by 3.93% to $635000.0 in 2019, then sank by 84.25% to $100000.0 in 2020, then surged by 349900.0% to $350.0 million in 2021, then slumped by 99.98% to $82984.0 in 2022.
According to Business Quant data, Receivables - Other over the past three periods registered $82984.0, $43057.0, and $24785.0 for Q4 2022, Q3 2022, and Q2 2022 respectively.

#	Company	Market Cap	Enterprise Value	Gross Profit (Qtr)
1	Abbott Laboratories	198.70 Bn	193.10 Bn	7.27 Bn
2	Stryker	125.85 Bn	122.37 Bn	4.50 Bn
3	Medtronic	118.44 Bn	109.22 Bn	6.41 Bn
4	Boston Scientific	72.64 Bn	72.10 Bn	3.85 Bn
5	Edwards Lifesciences	51.94 Bn	47.69 Bn	1.35 Bn
6	Dexcom	34.48 Bn	32.53 Bn	830.00 Mn
7	GE HealthCare Technologies	33.60 Bn	31.49 Bn	2.18 Bn
8	Koninklijke Philips	26.30 Bn	22.98 Bn	4.55 Bn
9	Steris	23.00 Bn	22.52 Bn	684.20 Mn
10	Guided Therapeutics	26.06 Mn	26.05 Mn	-

Download Data